Skip to main content
. 2023 Oct 7;36:102464. doi: 10.1016/j.pmedr.2023.102464

Table 2.

BSFI outcomes (sexual function domains, total BSFI score, and sexual satisfaction) among male COVID-19 survivors and NORM in China from February 4, 2023 to March 15, 2023, overall and age-stratified.

Sexual drive Erectile function Ejaculatory function Problem assessment Total BSFI score (overall sexual functioning) Sexual satisfaction
Total sample
NORM (n = 198) 2.56(0.72) 2.96(0.72) 3.40(0.78) 3.04(1.07) 29.95(6.6) 2.97(0.93)
COVID-19 survivors
(n = 1,052)
2.28(0.81) 2.81(0.79) 3.22(0.85) 2.63(1.16) 27.33(7.99) 2.62(1.14)
p valuea <0.001 0.012 0.0051 <0.001 <0.001 <0.001
SMDb −0.40 −0.21 −0.23 −0.38 −0.40 −0.38



18–29 years
NORM (n = 99) 2.61(0.78) 3.02(0.67) 3.49(0.72) 3.26(0.99) 31.06(5.7) 3.03(1)
COVID-19 survivors
(n = 417)
2.45(0.76) 2.96(0.66) 3.46(0.7) 2.97(1.05) 29.61(6.56) 2.86(1.02)
p valuea 0.0647 0.4035 0.6841 0.012 0.0439 0.1329
SMDb −0.20 −0.09 −0.04 −0.30 −0.25 −0.17



30–39 years
NORM (n = 41) 2.70(0.55) 3.07(0.73) 3.39(0.84) 2.89(1.14) 30.07(6.91) 3.00(0.89)
COVID-19 survivors
(n = 271)
2.31(0.81) 2.93(0.79) 3.25(0.79) 2.77(1.06) 28.20(7.56) 2.68(1.09)
p valuea 0.0038 0.2609 0.2774 0.489 0.1368 0.0744
SMDb −0.70 −0.20 −0.17 −0.11 −0.27 −0.36



40–49 years
NORM (n = 24) 2.54(0.83) 3.11(0.56) 3.46(0.87) 3.24(0.95) 31.04(7.07) 3.08(0.72)
COVID-19 survivors
(n = 240)
2.11(0.82) 2.61(0.86) 2.99(0.88) 2.19(1.2) 24.59(8.59) 2.31(1.27)
p valuea 0.0139 0.0054 0.0133 <0.001 0.0004 0.0036
SMDb −0.52 −0.89 −0.54 −1.11 −0.91 −1.08



>50 years
NORM (n = 34) 2.28(0.61) 2.56(0.82) 3.09(0.74) 2.46(1.09) 25.79(6.95) 2.71(0.87)
COVID-19 survivors
(n = 124)
1.93(0.77) 2.47(0.86) 2.77(1.06) 2.08(1.13) 23.02(8.83) 2.28(1.14)
p valuea 0.0154 0.5712 0.0976 0.0788 0.092 0.0469
SMDb −0.58 −0.11 −0.43 −0.35 −0.40 −0.49

Range score possible: sexual drive 0–4, erectile function 0–4, ejaculatory function 0–4, problem assessment 0–4, total BSFI score 0–40, sexual satisfaction 0–4.

Bold type indicating statistical significance (p value < 0.05) or moderate clinical significance (effect size ≥ 0.50).

Data are presented as mean (SD) unless otherwise specified.

BSFI Brief Sexual Function Inventory, NORM normative data, COVID-19 coronavirus disease 2019, SMD standardized mean difference.

a

Select independent sample t-test or variance analysis according to data type.

b

Equation: SMD =meansurvivors-meanNORMSDNROM.